• German
  • English
  • Spanish

About

Our Vision

We want all European patients to have access to the full therapeutic potential of phytocannabinoids. We will support continuative research on all substances of the cannabis plant and will assist to understand medical mechanisms of cannabinoids and terpenes even better in the future. We are certain that we can create multiple effective pharmaceuticals through proper application of natural cannabis – we want to be a leader in this field.

Our products that we distribute in Europe are built only to the highest pharmaceutical standards. We and our suppliers require exceptionally high standard to our quality assurance and management systems: From cultivation to packaging and distribution.

Unique and natural quality through cannabis cultivation

We develop specific cannabis genetics for different medicinal conditions and requirements. We cultivate the medical plants under highest agricultural production standards (EU-GAP) and security requirements in dedicated cannabis cultivation facilities that were built exclusively for that purpose.

Adequate intake forms through cannabis oils, extracts and flowers.

The cannabis plant has far above 400 differents substances that have been subject to little research only. Main ingredients are the phytocannabinoids like CBD and THC. The plant also contains terpenes like myrcene, limonene and beta-caryophyllene. All these substances can be of therapeutic use.

We know today that the interaction of different phytocannabinoids and terpenes can be particularly effective for certain therapeutic approaches (entourage-effect). We prefer the pharmaceutical use of the entire cannabis plant to realize its full medical potential. We refuse the chemical synthesis of singular cannabinoids for medical application.

To make the best cannabinoid medicine available for different patients and medical conditions we offer not only dried cannabis flowers to vaporize but also extracts as well as oils for the oral consumption.

Share on facebook
Share on twitter
Share on pinterest
Share on email
Share on print

Cannabis Becomes Medicine

HAPA pharm is an international company focused on the research, development and distribution of cannabinoid-containing drug formulations. We stand for a controlled cultivation of cannabis plants in the EU as well as for the own production of prescription medicines according to EU-GMP-guidelines.

Newsletter

© All rights reserved

HWG Disclaimer​

The therapeutic potential of cannabis is still largely unexplored. We have to point out that for cannabinoid therapy, reliable evidence of efficacy based on large randomized controlled clinical trials is available for only a few indications. Off-label and no-label prescriptions are therefore common. Therefore, the information presented on our website should not be misunderstood as a promise of healing or as a suggestion to try therapy with cannabis, but is merely for your information to stimulate medical and scientific discourse. We hope to provide you with a serious introduction to the complex topic of cannabinoid therapy on the basis of scientifically sound sources, but do not claim our info to be complete and recommend a deeper self-study of the topic to interested experts. If you notice errors on our pages, we thank you in advance for letting us know. If the medical terms or other content provided here cause you any difficulties in understanding, please ask your doctor or contact us.